[CLDX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -36.08%
YoY- 41.98%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 2,498 268 163 3,480 236 715 2,763 -1.66%
PBT -35,842 -30,502 -36,004 -13,373 -11,259 -11,779 -16,407 13.89%
Tax 0 -3,459 16,564 382 -228 -2,990 -15,798 -
NP -35,842 -30,502 -52,568 -13,373 -11,031 -11,779 -16,407 13.89%
Tax Rate - - - - - - - -
Total Cost 38,340 30,770 52,731 16,853 11,267 12,494 19,170 12.23%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -1,434.83 -11,381.34 -32,250.31 -384.28 -4,674.15 -1,647.41 -593.81 15.82%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.54 -0.65 -1.12 -0.34 -0.50 -0.84 -1.67 -17.13%
EPS Diluted -0.54 -0.65 -1.12 -0.34 -0.50 -0.84 -1.67 -17.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.